ALI ASIF (Chief Financial Officer) sold 2.9% of their position (1.75K shares) of PROTAGONIST THERAPEUTICS, INC on the open market
Open‑market sale worth $184.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/21/2026ACC: 0001104659-26-046110
Officer· Chief Financial Officer
Since Apr 2022
-1.75K
Net shares
Net seller
$184.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.75K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.75K
Price / share
$105.47
Trade value
$184.57K
% of position
2.9%
4/20/2026
60.75K→59K
Total
Net shares
−1.75K
Net value
-$184.57K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/20/2026 | S · Sale | −1.75K | $105.47 | $184.57K | 2.9% | 60.75K | 59K |
| Total | −1.75K | -$184.57K | ||||||
Derivative Transactions0
No derivative transactions reported